<DOC>
	<DOCNO>NCT01449500</DOCNO>
	<brief_summary>To determine whether simultaneous use L. reuteri ProGastria proton pump inhibitor eradicate H. pylorus human absence antibiotic .</brief_summary>
	<brief_title>Supplementation With L. Reuteri H. Pylori Infected Adults</brief_title>
	<detailed_description>Fifty-six ( 56 ) subject , age 18-70 year recruit patient dyspeptic symptom refer clinic consultation H. pylori infection previously treat infection . Patients H. pylori infection confirm ( endoscopy biopsy ) fulfil inclusion criterion , invite enter study . After write consent obtain subject randomly allocate one two group , one receive omeprazole ( 2x20mg/day ) + 1 tablet placebo per day receive omeprazole ( 2x20mg/day ) + 1 tablet ( 2x108 CFU L. reuteri ) ProGastria per day . After randomisation Day 0 study , subject also ask complete gastrointestinal symptom rating score ( GSRS ) determine baseline symptomology . Intervention begin Day 1 last 28 day therapy stop . The subject ask complete GSRS questionnaire Day 14 Day 28 . At Day 14 , patient GSRS score monitor patient interview . In patient marked deterioration condition symptom , consider treatment failure eradication therapy start Day 15 . The day therapy stop ( Day 29 ) , patient symptom assess . All patient undergo gastroscopy determine presence H. pylorus . If H. pylorus infection confirm ( endoscopy biopsy stain ) , subject give triple therapy eradicate infection follow Day 90 study . On Day 29 , patient longer complain symptom show free H. pylorus infection endoscopy ( treatment success group ) , continue therapy Day 90 . On Day 90 subject give UBT determine presence H. pylori infection symptom assess use GSRS . Asymptomatic patient negative breath test consider recover . In patient persistent H. pylorus infection confirm breath test , second line therapy implement indicated .</detailed_description>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<criteria>Subjects age 1870 year Infection H. pylorus define endoscopic examination biopsy H. pylorus stain Nonulcer dyspepsia Absence pathology show basic clinical laboratory test ( blood urine ) well abdominal ultrasound No early eradication therapy H. pylori infection Written inform consent Stated availability throughout entire study period Mental ability understand willingness fulfil detail protocol . Duodenal gastric ulcer MALT lymphoma Gastric resection ( time ) First level relative gastric cancer patient Absence GI symptom Use NSAIDs , aspirin antiinflammatory drug within 1 week ( occasional use ) 3 week ( chronic use ) inclusion Use oral antibiotic and/or PPIs and/or H2antagonists 2 week prior ingestion study product Pregnancy Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Dyspeptic H.pylori-infection</keyword>
</DOC>